Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits.
Level 5 - mechanism / opinion, no new human data
Narrative review of existing literature without systematic review methodology
PubMed 29350557 · doi:10.1146/annurev-food-111317-095850
What was done
This narrative review synthesized literature on the structural features, dietary sources, metabolism, bioavailability, and health effects of omega-3 polyunsaturated fatty acids—including α-linolenic acid (ALA), stearidonic acid (SDA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). Health outcomes covered include cardiovascular disease, diabetes, cancer, Alzheimer's disease, dementia, depression, visual and neurological development, and maternal-child health.
What was found
The abstract reports no quantitative results, effect sizes, or specific risk estimates. It notes that while numerous epidemiological and clinical benefits have been documented for omega-3 PUFAs across multiple disease categories, controversies persist regarding their clinical efficacy for certain health outcomes.
Why it matters
It provides a broad reference summarizing the biochemistry, sources, and proposed clinical applications of various omega-3 fatty acids across major human organ systems.
Limits
The abstract describes a broad narrative overview rather than a systematic review or meta-analysis. No inclusion criteria, search strategy, study quality grading, or pooled quantitative data are reported.
Cited by
- supports Alpha-linolenic acid (ALA) is an 18-carbon fatty acid, whereas EPA is 20 carbons and DHA is 22 carbons.